MMP14 and sensorineural hearing loss disorder: Future studies warrant further investigations into whether antibody- or small-molecule mediated MMP-14 inactivation could in turn prevent cochlear explant damage, and possibly the use of clinical MMP inhibitors to alleviate SNHL.